Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 659 of 1,261
  1. US 9517262

    Vaccine injection, preparation method and use thereof

    CHINA 302 MILITARY HOSPITAL OF PLA · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  2. US 9518056

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  3. US 9517243

    Beta-mannosylceramide and stimulation of NKT cell anti-tumor immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  4. US 9518091

    A4B7 peptide monomer and dimer antagonists

    Protagonist Therapeutics, Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  5. US 9517233

    Local cochlear application of statins for stimulating neurite regrowth in the cochlea

    Northwestern University · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  6. US 9517067

    System and method for satellite drug delivery

    Covidien LP · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  7. US 9518260

    Pain treatment

    Benitec Biopharma Limited · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  8. US 9518096

    Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

    Takeda Vaccines, Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  9. US 9518262

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  10. US 9518259

    Compounds and methods for modulating interaction between proteins and target nucleic acids

    Ionis Pharmaceuticals, Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  11. US 9518080

    Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  12. US 9518090

    Compositions and methods for treating hepatitis B

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  13. US 9518050

    Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity

    Almirall, S.A. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  14. US 9518042

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  15. US 9518040

    GDF-8 inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  16. US 9517276

    Compositions and methods for conjugating activatable antibodies

    CytomX Therapeutics, Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  17. US 9517270

    Lipocationic polymers and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  18. US 9517224

    Methods of treating patients infected with HIV and HTLV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  19. US 9511115

    Pharmaceutical compositions for treating or preventing bone conditions

    The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  20. US 9511075

    Targeting NCCA-ATP channel for organ protection following ischemic episode

    The United States of America as Represented by the Dept. of Veterans Affairs · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  21. US 9511103

    AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  22. US 9511038

    Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

    The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  23. US 9511058

    Methods for using carboxamide, sulfonamide and amine compounds

    Rigel Pharmaceuticals, Inc. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  24. US 9512481

    Polymorphisms in the PDE3A gene

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.